Elevance Health Inc. (ELV) is a Medical - Healthcare Plans company in the Healthcare sector, currently trading at $313.35. It has a SharesGrow Score of 62/100, indicating a above average investment profile with 3 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of ELV = $848.27 (+170.7% from the current price, the stock appears undervalued). Analyst consensus target is ELV = $383 (+22.1% upside).
Valuation: ELV trades at a trailing Price-to-Earnings (P/E) of 12.4 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 0.99.
Financials: revenue is $199.1B, +8.4%/yr average growth. Net income is $5.7B, growing at -1.3%/yr. Net profit margin is 2.8% (thin). Gross margin is 25.6% (+0.1 pp trend).
Balance sheet: total debt is $33.2B against $43.9B equity (Debt-to-Equity (D/E) ratio 0.76, moderate). Current ratio is 1.24 (adequate). Debt-to-assets is 27.4%. Total assets: $121.5B.
Analyst outlook: 26 / 37 analysts rate ELV as buy (70%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 69/100 (Pass), Growth 40/100 (Partial), Past 100/100 (Pass), Health 50/100 (Partial), Moat 63/100 (Partial), Future 79/100 (Pass), Income 30/100 (Fail).
